Journal of Nephropharmacology (Jan 2023)

Antioxidants and cisplatin nephrotoxicity; an updated review on current knowledge

  • Ramin Tolouian,
  • Audrey Tolouian,
  • Farzaneh Dastan,
  • Vida Farhangi,
  • Payam Peymani,
  • Sanam Saeifar,
  • Oscar Felipe Borja Montes,
  • Leila Mohmoodnia,
  • Mohammadreza Khosravifarsani,
  • Tella Sadighpour

DOI
https://doi.org/10.34172/npj.2022.10556
Journal volume & issue
Vol. 12, no. 1
pp. e10556 – e10556

Abstract

Read online

Cisplatin is a first-line antitumor drug which is applied in the therapeutic field of numerous kinds of cancers. The main dose-dependent adverse effect of cisplatin is nephrotoxicity in approximately one-third of patients, who received this drug during their treatment. Oxidative stress is one of the most significant mechanisms in cisplatin nephrotoxicity. Cisplatin-induced oxidative stress stimulates apoptosis, inflammation, mitochondrial damage within cells, and endoplasmic reticulum (ER) stress. The administration of an antioxidant in this context could be a suitable approach for preventing of cisplatin nephrotoxicity. Antioxidants are categorized into four classes: dietary antioxidants, free radical scavengers, thiol-containing compounds, and iron chelators.

Keywords